Rxivist logo

EDEM3 modulates plasma triglyceride level through its regulation of LRP1 expression

By Yu-Xin Xu, Gina M Peloso, Taylor H Nagai, Taiji Mizoguchi, Amy Deik, Kevin Bullock, Honghuang Lin, Kiran Musunuru, Qiong Yang, Ramachandran S Vasan, Robert E Gerszten, Clary B. Clish, Daniel Rader, Sekar Kathiresan

Posted 31 Aug 2019
bioRxiv DOI: 10.1101/742353 (published DOI: 10.1016/j.isci.2020.100973)

Human genetics studies have uncovered genetic variants that can be used to guide biological research and prioritize molecular targets for therapeutic intervention for complex diseases and metabolic conditions. We have identified a missense variant (P746S) in EDEM3 associated with lower blood triglyceride (TG) levels in >300,000 individuals. Functional analyses in cell and mouse models show that EDEM3 deficiency strongly increased the uptake of very low-density lipoprotein and thereby reduced the plasma TG level, as a result of up-regulated expression of LRP1 receptor. We demonstrate that EDEM3 deletion up-regulated the pathways for RNA and ER protein processing and transport, and consequently increased the cell surface mannose-containing glycoproteins, including LRP1. Metabolomics analyses reveal a cellular TG accumulation under EDEM3 deficiency, a profile consistent with individuals with carrying EDEM3 P746S. Our study identifies EDEM3 as a regulator of blood TG, and targeted inhibition of EDEM3 may provide a complementary approach for lowering elevated blood TG concentrations.

Download data

  • Downloaded 323 times
  • Download rankings, all-time:
    • Site-wide: 50,076 out of 89,518
    • In genetics: 2,855 out of 4,628
  • Year to date:
    • Site-wide: 34,116 out of 89,518
  • Since beginning of last month:
    • Site-wide: 53,229 out of 89,518

Altmetric data


Downloads over time

Distribution of downloads per paper, site-wide


PanLingua

Sign up for the Rxivist weekly newsletter! (Click here for more details.)


News